PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis • Global transplant diagnostics market by molecular assays • Global transplant diagnostics market by non-molecular assays PART 06: Market segmentation by screening • Pre-transplant diagnostics • Post-transplant diagnostics PART 07: Market segmentation by product • Reagents and consumables • Instruments PART 08: Market segmentation by end-user PART 09: Market segmentation by application • Stem cell transplantation • Organ transplantation PART 10: Geographical segmentation • Transplant diagnostics market in Americas • Transplant diagnostics market in EMEA • Transplant diagnostics market in APAC PART 11: Market drivers • Prevalence of chronic diseases • Public awareness of organ donation • Growth opportunities in emerging markets PART 12: Impact of drivers PART 13: Market challenges • Unfavorable reimbursement scenario • Limited technical expertise • High cost of transplant diagnostics PART 14: Impact of drivers and challenges PART 15: Market trends • Advances in technology • Government initiatives • Product approvals and launches • Increase in M&A PART 16: Vendor landscape • Competitive scenario PART 17: Major vendors • Bio-Rad Laboratories • CareDx • Illumina • Immucor • Linkage Biosciences • Thermo Fisher Scientific • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Types of HLA testing used to determine compatibility Exhibit 03: Global transplant diagnostics market 2015-2020 ($ millions) Exhibit 04: Five forces analysis Exhibit 05: Global transplant diagnostics market segmentation by technique Exhibit 06: Global transplant diagnostics market segmentation by technique 2015 Exhibit 07: Global transplant diagnostics market segmentation by technique 2020 Exhibit 08: PCR techniques: Advantages and disadvantages Exhibit 09: Global transplant diagnostics market by molecular assays 2015-2020 ($ millions) Exhibit 10: Global transplant diagnostics market by non-molecular assays 2015-2020 ($ millions) Exhibit 11: Global transplant diagnostics market segmentation by screening 2015 Exhibit 12: Global transplant diagnostics market segmentation by screening 2020 Exhibit 13: Overview of pre- and post-transplant diagnosis Exhibit 14: Global pre-transplant diagnostics market 2015-2020 ($ millions) Exhibit 15: Global post-transplant diagnostics market 2015-2020 ($ millions) Exhibit 16: Some reagents, consumables, and instruments available commercially Exhibit 17: Global transplant diagnostics market by product 2015 Exhibit 18: Global transplant diagnostics market by product 2020 Exhibit 19: Global transplant diagnostics market segmentation by end-user 2015 Exhibit 20: Global transplant diagnostics market segmentation by end-user 2020 Exhibit 21: Global transplant diagnostics market segmentation by application Exhibit 22: Global transplant diagnostics market segmentation by organ transplantation 2015 Exhibit 23: Global transplant diagnostics market segmentation by organ transplantation 2020 Exhibit 24: Deceased donors for different organs 2015 Exhibit 25: Living donors for different organs 2015 Exhibit 26: Global transplant diagnostics market segmentation by geography 2015 Exhibit 27: Global transplant diagnostics market segmentation by geography 2020 Exhibit 28: Global transplant diagnostics market segmentation by geography 2015-2020 Exhibit 29: Transplant diagnostics market in Americas 2015-2020 ($ millions) Exhibit 30: Transplant diagnostics market in EMEA 2015-2020 ($ millions) Exhibit 31: Transplant diagnostics market in APAC 2015-2020 ($ millions) Exhibit 32: Impact of drivers Exhibit 33: Price of sequencers of different companies Exhibit 34: Impact of drivers and challenges Exhibit 35: Bio-Rad Laboratories: Product portfolio Exhibit 36: Bio-Rad Laboratories: Revenue of clinical diagnostics segment 2013-2015 ($ billions) Exhibit 37: Bio-Rad Laboratories: Key takeaways Exhibit 38: CareDx: Product portfolio Exhibit 39: CareDx: AlloSure clinical studies Exhibit 40: CareDx: Key takeaways Exhibit 41: Illumina: Product portfolio Exhibit 42: Illumina: Key takeaways Exhibit 43: Immucor: Product portfolio Exhibit 44: Immucor: Revenue of transplant and molecular segment 2013-2015 ($ millions) Exhibit 45: Immucor: Key takeaways Exhibit 46: Linkage Biosciences: Product portfolio Exhibit 47: Linkage Biosciences: Key takeaways Exhibit 48: Thermo Fisher Scientific: Product portfolio Exhibit 49: Thermo Fisher Scientific: Revenue of specialty diagnostics segment 2013-2015 ($ billions) Exhibit 50: Thermo Fisher Scientific: Key takeaways Exhibit 51: Other prominent vendors

Bio-Rad Laboratories, CareDx, Illumina, Immucor, Linkage Biosciences, Thermo Fisher Scientific, Abbott Laboratories, Becton Dickinson, Danaher, F. Hoffmann-La Roche, HistoGenetics, Ortho Clinical Diagnostics, Oxford Immunotec, Qiagen, Siemens, Sigma-Aldrich, Tosoh Bioscience.